# Ne oldu?

Nature Medicine has issued a published erratum correcting author names and affiliations for the article titled "Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms." This correction does not introduce new scientific data, clinical conclusions, or revised findings; it addresses author attribution errors identified post-publication.

# Ayrıntılar

The erratum, published under DOI 10.1038/s41591-026-04613-1, updates the byline and institutional listings associated with the original research. The underlying study, which investigates the genomic landscape of histiocytic neoplasms, remains unchanged in its results and conclusions. The correction affects the identification of contributors but does not alter the experimental outcomes or biological interpretations presented in the primary article.

# Neden önemli?

While errata are routine in academic publishing, this correction is notable for involving a high-impact oncology journal and a topic of significant clinical relevance. Activating mutations in CSF1R and associated receptor tyrosine kinases represent a growing area of interest in histiocytic and related myeloid neoplasms, with implications for targeted therapy development. Ensuring accurate author attribution maintains the integrity of the scientific record in this field.

# Sırada ne var?

The scientific community continues to monitor the role of CSF1R and related kinase alterations in histiocytic disorders. Future research will focus on the clinical validation of targeted inhibitors and the refinement of genomic classification systems. No further author corrections or data revisions have been announced at this time.